Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2007-12-04
2007-12-04
Bragdon, Kathleen Kerr (Department: 1656)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S300000, C424S435000
Reexamination Certificate
active
09885725
ABSTRACT:
The present invention relates to the surprising finding that enamel matrix, enamel matrix derivatives and/or enamel matrix proteins induce dentin regeneration. The invention thus relates to the use of a preparation of an active enamel substance for the preparation of a pharmaceutical composition for the formation or regeneration of dentin following dental procedures involving exposure of vital dental pulp tissue. In another aspect, the invention relates to a method of promoting the formation or regeneration of dentin following dental procedures involving exposure of vital dental pulp tissue, the method comprising applying an effective amount of an active enamel substance on exposed vital dental pulp tissue after dental procedures.
REFERENCES:
patent: 6300062 (2001-10-01), Cerny et al.
patent: 6503539 (2003-01-01), Gestrelius et al.
patent: WO 97/02730 (1997-01-01), None
patent: WO 99/43344 (1999-09-01), None
Nakamura, M. et al. Anat Rec. 238(3):383-396 (1994).
Ruch, J.V. et al. Int. J. Dev. Biol. 39: 51-68 (1995).
Sasaki, T. and Kido, H. Archs oral Biol. 40(3): 209-219 (1995).
Cox et al., “Biocompatibility of various dental materials: pulp healing with surface seal”, Int J Periodont Rest Dent 16: 241-251 (1996).
Kiba et al., “Pulpal reactions to two experimental bonding systems for pulp capping procedures”, Journal of Oral Sciences 42(2): 69-74 (2000).
L. Hammarstrom: Enamel matrix, cementum development and regenerationJ. Clin. Periodontol. 1997; 24: pp. 658-668.
Fincham et al., Self-Assembly of a Recombinant Amelogenin Protein Generates Supramolecular Structures.J. Struct. Biol.Mar.-Apr. 1994; 112(2):103-9.
Fincham et al., Evidence for Amelogenin “Nanospheres” as Functional Components of Secretory-State Enamel Matrix.J. Struct. Biol.Jul.-Aug. 1995; 115(1):50-9.
Gestrelius S. Andersson C, Johansson AC, Persson E, Brodin A, Rydhag L, Hammarstrom L (1997). Formulation of enamel matrix derivative for surface coating. Kinetics and cell colonization.J. Clin Periodontol, 24: 678-684.
Lyngstadaas SP, Lundberg E, Ekdahl H, Andersson C, Gestrelius S (2001). Autocrine growth factors in human periodontal ligament cells cultured on enamel matrix derivative.J. Clin Periodontol, Feb;28(2):181-8.
T. Inai et al.: “Demonstration of amelogenin in the enamel-free cusps of rat molar tooth germs: Immunofluorescent and immunoelectron microscopic studies.” The Anatomical Record, vol. 233 No. 4, Aug. 1992, pp. 588-596.
James T. Mellonig; “Enamel Matrix Derivative for Periodontal Reconstructive Surgery; Technique and Clinical and Histologic Case Report” International Journal of Peridontics & Restorative Dentistry, vol. 19, No. 1, Feb. 1999, pp. 9-19.
A.R. Ten Cate:Oral Histology, Development, sttructure and Function,3rdEd., Mosby 1989, pp. 150-196.
Gestrelius Stina
Lyngstadaas Ståle Petter
Biora AB
Bragdon Kathleen Kerr
Desai Anand
Rissman Jobse Hendricks & Oliverio LLP
LandOfFree
Matrix protein composition for dentin regeneration does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Matrix protein composition for dentin regeneration, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Matrix protein composition for dentin regeneration will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3857904